Status:
COMPLETED
Long-Standing Persistant Atrial Fibrillation-Pulmonary Vein Isolation With or Without Ablation
Lead Sponsor:
Asklepios proresearch
Conditions:
Atrial Fibrillation
Tachycardia
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The chronic success rate, defined as freedom from any atrial tachyarrhythmias will increase from 35% to 60% by ablation of complex fragmented atrial electrograms potentials in addition to pulmonary ve...
Eligibility Criteria
Inclusion
- long standing persistent atrial fibrillation \> 6 months and \< 5 years
Exclusion
- renal failure
- left atrial size \>55 mm
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2017
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT00820625
Start Date
May 1 2008
End Date
February 1 2017
Last Update
February 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asklepios Klinik St. Georg
Hamburg, Germany